RE:RE:Northern Capital.. Best ( $86 US ) and Worst ( $61 US ) WorsWhat we do know ia that Blackstone would not offer a price anywhere near the current share price.
The fundamentals are superb, and will get better as more and more of its drugs are manufactured in India and those in late stage aproval become approved.
No other mid level Pharma is as well diversfieid as CXR, both by its drug suite and geographically.
Amdipharm also provided CXR with strong organic growth for the next 5 years.
And they pay a dividend.
I added several more thousands today.
Friday will be a quickj turnaround..